Uma cura controversa: A promessa biomédica para a hanseníase em Portugal e no Brasil

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

This paper aims to answer the following question that arouse during fieldwork: why some people with hanseniasis and treated with multidrug therapy (MDT) feel healed and others don’t? From a multi-sited ethnography in the transnational (global program for hanseniasis from the World Health Organization), national (Portuguese and Brazilian moral landscapes and biopolitical paradigms), local (clinical practice and incorporated experience of people with hanseniasis in both countries) scales, it examines how the uncertainty documented in the clinic and the gap experienced by some people between the bacteriological cure and the feeling of being healed, opens for a controversy on the main postulates that sustain the use of MDT as an autonomous entity and diffract the contemporaneous framing of hanseniasis and the institutional responses to it. Finally, it concludes on the need for including an incorporated choice that might widen hanseniasis’ ontological politics and rebuild a new participatory paradigm of care.

Cite

CITATION STYLE

APA

Cruz, A. (2016). Uma cura controversa: A promessa biomédica para a hanseníase em Portugal e no Brasil. Physis, 26(1), 25–44. https://doi.org/10.1590/S0103-73312016000100004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free